Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure

Medical Journal of Australia

Volumn 193, Issue 9, 2010, Pages 555-

  Towers, Kate A ^a   Bardsley, Kimberley A ^a   Macdonald, Peter S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; FUROSEMIDE; GLYCERYL TRINITRATE; ISOPHANE INSULIN; OMEPRAZOLE; OXYGEN; SIMVASTATIN; SPIRONOLACTONE; WARFARIN;

AGED; CASE REPORT; CONGESTIVE HEART FAILURE; DIURESIS; DYSPNEA; HUMAN; LETTER; LUNG EDEMA; MALE; NEBULIZATION; OXYGEN SATURATION;

AGED, 80 AND OVER; DIURETICS; DYSPNEA; FUROSEMIDE; HEART FAILURE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS;

EID: 78149320595     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Newton PJ, Davidson PM, Macdonald P, et al. Nebulized furosemide for the management of dyspnea: does the evidence support its use? J Pain Symptom Manage 2008; 36: 424-441.